ArticleDiabetes, obesity & metabolism2019

Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real-world clinical evidence.

Pedro Mezquita Raya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.